Methylprednisolone sodium succinate and Necrotising fasciitis streptococcal - a phase IV clinical study of FDA data
Necrotising fasciitis streptococcal is reported only by a few people who take Methylprednisolone Sodium Succinate.
The phase IV clinical study analyzes which people take Methylprednisolone sodium succinate and have Necrotising fasciitis streptococcal. It is created by eHealthMe based on reports of 10,060 people who have side effects while taking Methylprednisolone sodium succinate from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
10,060 people reported to have side effects when taking Methylprednisolone sodium succinate.
Among them, 2 people (0.02%) have Necrotising fasciitis streptococcal.
What is Methylprednisolone sodium succinate?
Methylprednisolone sodium succinate has active ingredients of methylprednisolone sodium succinate. eHealthMe is studying from 10,070 Methylprednisolone sodium succinate users for its effectiveness, alternative drugs and more.
What is Necrotising fasciitis streptococcal?
Necrotising fasciitis streptococcal (an uncommon life threatening soft tissue infection by streptococcal) is found to be associated with 140 drugs and 71 conditions by eHealthMe.
Number of Methylprednisolone sodium succinate and Necrotising fasciitis streptococcal reports submitted per year:
Gender of people who have Necrotising fasciitis streptococcal when taking Methylprednisolone sodium succinate *:
- female: 50 %
- male: 50 %
Age of people who have Necrotising fasciitis streptococcal when taking Methylprednisolone sodium succinate *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 50 %
- 40-49: 50 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common side effects people have besides Necrotising fasciitis streptococcal *:
- Streptococcal Bacteraemia (a bacterial infection of blood): 1 person, 50.00%
- Septic Shock (shock due to blood infection): 1 person, 50.00%
- Rashes (redness): 1 person, 50.00%
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Methylprednisolone sodium succinate and have Necrotising fasciitis streptococcal?Check whether Necrotising fasciitis streptococcal is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Methylprednisolone sodium succinate:
- Methylprednisolone sodium succinate (10,070 reports)
Necrotising fasciitis streptococcal treatments and more:
- Necrotising fasciitis streptococcal (138 reports)
COVID vaccines that are related to Necrotising fasciitis streptococcal:
- Necrotising fasciitis streptococcal in Moderna COVID Vaccine
- Necrotising fasciitis streptococcal in Pfizer BioNTech Covid Vaccine
- Necrotising fasciitis streptococcal in Johnson and Johnson Covid Vaccine
How severe was Necrotising fasciitis streptococcal and when was it recovered:
Expand to all the drugs that have ingredients of methylprednisolone sodium succinate:
- Necrotising fasciitis streptococcal and drugs with ingredients of methylprednisolone sodium succinate
All the drugs that are associated with Necrotising fasciitis streptococcal:
- Necrotising fasciitis streptococcal (140 drugs)
All the conditions that are associated with Necrotising fasciitis streptococcal:
- Necrotising fasciitis streptococcal (71 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on methylprednisolone sodium succinate (the active ingredients of Methylprednisolone sodium succinate) and Methylprednisolone sodium succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Carvedilol and Ketoconazole drug interaction - 7 seconds ago
- Estrace and Hydrocodone Bitartrate And Acetaminophen drug interaction - 11 seconds ago
- Mepron and Sandostatin Lar drug interaction - 16 seconds ago
- Milk Of Magnesia and Bladder Spasm - 20 seconds ago
- Efavirenz and Azithromycin drug interaction - 22 seconds ago